View More Recent Stories

Feb 5, 2015 06:45AM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2015 Leerink Global Healthcare Conference
Jan 30, 2015 04:02PM Sucampo Appoints Andrew Smith, FCMA, CGMA as CFO
Jan 21, 2015 06:45AM Robert J. Spiegel, M.D., FACP Joins Sucampo's Board of Directors
Dec 30, 2014 05:00PM Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada
Dec 15, 2014 06:45AM Sucampo Appoints John H. Johnson to Board of Directors
Nov 12, 2014 05:31PM Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy's
Nov 11, 2014 06:45AM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Stifel 2014 Healthcare Conference
Nov 6, 2014 06:45AM Sucampo Announces Third Quarter 2014 Financial Results
Oct 24, 2014 06:45AM Sucampo Pharmaceuticals, Inc. Announces Third Quarter 2014 Earnings Call
Oct 23, 2014 04:02PM Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development, Regulatory Affairs
Oct 21, 2014 06:00PM Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
Oct 14, 2014 06:45AM Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda
Oct 13, 2014 06:45AM Clinical Data for AMITIZA(R) Lubiprostone to be Presented at the American College of Gastroenterology 2014 Annual Scientific Meeting
Oct 9, 2014 04:45PM Sucampo Announces Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA
Oct 6, 2014 04:02PM Sucampo Announces Departure of Chief Financial Officer
Sep 29, 2014 06:45AM Sucampo and Takeda Launch Direct-to-Consumer Advertising Campaign for AMITIZA(R) (lubiprostone) for Chronic Idiopathic Constipation
Aug 21, 2014 04:30PM Sucampo Announces New Exclusive Global Manufacturing and Supply Agreement for Lubiprostone
Aug 5, 2014 06:15AM Sucampo Reports Second Quarter 2014 Financial Results and Corporate Update
Jul 23, 2014 06:45AM Sucampo Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone)
Jul 22, 2014 06:45AM Sucampo Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results and Corporate Update Teleconference and Webcast on August 5
Jul 7, 2014 04:48PM Swissmedic Approves AMITIZA(R) (Lubiprostone) for the Treatment of Opioid-Induced Constipation
Jun 12, 2014 02:41PM Sucampo Issues Statement Regarding Anesthetic and Analgesic Drug Products Advisory Committee Meeting's Vote
May 29, 2014 06:45AM Sucampo Announces Webcast of Its Presentation at 2014 Jefferies Global Healthcare Conference
May 13, 2014 04:02PM Sucampo Announces Webcast of Its Presentation at the 2014 UBS Global Healthcare Conference
May 7, 2014 04:02PM Sucampo Pharmaceuticals, Inc., Reports First Quarter 2014 Financial and Operating Results
May 1, 2014 06:45AM Sucampo Announces Clinical Data on Lubiprostone to be Presented at Two Upcoming Scientific Conferences
Apr 30, 2014 06:45AM Sucampo Pharmaceuticals Announces First Quarter 2014 Results and Operating Highlights Teleconference and Webcast
Apr 25, 2014 04:08PM Preclinical Data for Lubiprostone and Unoprostone Isopropyl to be Presented at Experimental Biology Conference 2014
Mar 25, 2014 06:45AM Sucampo Co-Founder and Chairman Emeritus, Dr. Ryuji Ueno, to Receive Visionary Award From the Foundation Fighting Blindness
Mar 14, 2014 05:29PM Sucampo and Takeda Announce Update on Liquid Formulation Program for AMITIZA(R) (lubiprostone)
Mar 12, 2014 08:00PM Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.
Mar 5, 2014 04:02PM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 ROTH Conference
Mar 4, 2014 10:00AM Sucampo and National Cherry Blossom Festival Announce Sucampo as Host and 'Step Into Spring' Program Sponsor for 2014
Feb 26, 2014 04:02PM Sucampo Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating Results
Feb 10, 2014 04:02PM Sucampo Names Peter Greenleaf Chief Executive Officer
Feb 6, 2014 06:45AM All Physicians in Switzerland Are Now Able to Prescribe Sucampo's AMITIZA(R) for Chronic Idiopathic Constipation
Dec 23, 2013 06:45AM Sucampo Reports Results from Phase 2a Study of Intravenous Ion Channel Activator for Lumbar Spinal Stenosis
Dec 17, 2013 06:45AM Sucampo and Takeda Initiate Global Pivotal Phase 3 Program of Lubiprostone in Pediatric Functional Constipation
View More Recent Stories